Envestnet Asset Management Inc Nuvation Bio Inc. Transaction History
Envestnet Asset Management Inc
- $326 Billion
- Q2 2025
A detailed history of Envestnet Asset Management Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 47,419 shares of NUVB stock, worth $172,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,419Holding current value
$172,130% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
195Shares Held
168MCall Options Held
2.31MPut Options Held
221K-
Decheng Capital LLC Menlo Park, CA26MShares$94.2 Million12.78% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$58.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$57.7 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA11MShares$40.1 Million46.36% of portfolio
-
Laurion Capital Management LP New York, NY10.2MShares$37.2 Million0.37% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $789M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...